Beneficial Effects of Anticoagulants on the Clinical Outcomes of COVID-19 Patients
(1) Background: Severe coronavirus disease can be complicated by a hypercoagulable state in conjunction with sepsis, increasing the risk of venous thromboembolism. This study aimed to observe the effect of anticoagulants on 30-day high-dependency unit (HDU) outcomes of moderate to severe coronavirus...
Guardado en:
Autores principales: | Zubia Jamil, Azmat Ali Khan, Samreen Khalid, Muhammad Asghar, Khalid Muhammad, Yasir Waheed |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5aa55937f1ab42d8a8abdafe58387173 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vaccinated Patients Admitted in ICU with Severe Pneumonia Due to SARS-CoV-2: A Multicenter Pilot Study
por: Ángel Estella, et al.
Publicado: (2021) -
Hiponatremia e hiperpotasemia persistente inducida por enoxaparina y revertida con hidrocortisona en paciente con metástasis lumbares
por: Eymin,Gonzalo
Publicado: (2021) -
A case of paroxysmal complete atrioventricular block in a COVID‐19 patient
por: Hong Nyun Kim, et al.
Publicado: (2021) -
The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
por: Pieter M.M. De Kesel, et al.
Publicado: (2020) -
A Case of Thrombocytosis Associated with Enoxaparin Therapy in an Adolescent
por: Murray R, et al.
Publicado: (2021)